D5 Capital advises Incisive Health on sale to UDG Healthcare PLC for up to £13.6m

May 21st, 2019|0 Comments

21 May 2019: UDG Healthcare plc (“UDG Healthcare” or "the Group"), a leading international healthcare services provider, announced today the acquisition of  Incisive Health, a UK-based healthcare policy and communications consultancy, for a total consideration of up to £13.6 million ($17.7 million). D5 Capital sourced, negotiated and managed the transaction through to completion. Incisive Health will join Ashfield Communications and Advisory, a wholly-owned subsidiary of UDG. Incisive Health Incisive Health is a UK-based healthcare communications consultancy, which specialises in healthcare policy, public affairs and communication services. Incisive Health was founded by Mike Birtwistle, Sarah Winstone and Bill Morgan in 2013. Across its head office in London and an office in Brussels, the consultancy employs 36 people and provides a suite of consultancy and communications services including clinical advocacy, corporate and digital communications, direct payer engagement, public affairs, stakeholder campaigning, strategic and policy development and training programmes. Incisive Health has a diversified client base of predominately pharmaceutical and biotech companies. Incisive Health significantly strengthens UDG Healthcare’s capabilities in the UK and mainland Europe, specifically in dedicated policy and market access communications. Incisive Health is being acquired for a total consideration of up to £13.6 million ($17.7 million). This includes initial consideration of £8 million ($10.4 million), with an earn-out of up to £5.6 million ($7.3 million) payable over the next three years, based on the achievement of agreed profit targets. The transaction will be financed in cash and is expected to deliver a return on capital employed in excess of the Group’s target of 15% within three years. Commenting on the acquisition, Brendan McAtamney, CEO of UDG Healthcare plc, said: “We are pleased to announce the acquisition of Incisive Health, which further enhances our capabilities in Ashfield Communications and Advisory. Incisive Health adds specialist capability in the growing area of public health advocacy, supporting clients to secure market access for their brands, in addition to wider communications services.” Commenting on the transaction, Mike Birtwistle, Founding Partner of Incisive Health, said: “We wanted to find a partner who would deepen rather than dilute our specialism in healthcare and UDG Healthcare is perfect in this respect. D5 Capital was superb throughout the process, drawing on Rupert Ashe’s experience of other deals to ensure that we found a match who will help us achieve our ambitions for Incisive Health. D5 Capital were also great at handling much of the day-to-day deal discussions, freeing us up to focus on running a successful business.” For Further Information: Rupert Ashe, D5 Capital             +44 (0)7901 745740                  rupert@d5capital.com

D5 Capital advises Incisive Health on sale to UDG Healthcare PLC for up to £13.6m

Spot.IM socialising the Web

Spot.im raises $25 million for community creation and moderation tools

Lansons to acquire New York based Intermarket

Threads Raises $20m Series A Funding from C Ventures and Highland Europe

WARC sold to Ascential plc for £24m

PlaySight Interactive Extends Series C Funding to $21 million – New funding from SoftBank Ventures Korea and CE Ventures, following investments from Greg Norman, Verizon Ventures, others

ICF to Acquire The Future Customer; D5 Capital Advises The Future Customer Shareholders

Spot.IM Closes $25 Million Series C Led by Insight Venture Partners

Picfair raises £1.5m

Consumer Insight App OnePulse Closes $3 Million Seed Funding Round Ahead of United States Launch

PlaySight Announces $11m Investment from Verizon Ventures and Greg Norman

D5 Capital advises This Place Limited on sale to Infoteria of Japan

D5 Capital advises JPESPartners on acquisition of DL Media

Tailify launch Social Native Platform in UK

Picfair Raises Seed Round

Annacone and Cahill join PlaySight

D5 Capital and Lexinta Group to co-host PlaySight private investment road show in Zurich

Easy Payment Gateway Raises Expansion Capital

D5 Capital raises seed round for Connecteam

D5 Capital raises £1.6m Series A for MyShowcase

D5 Capital advises System Analytic on sale to WPP

D5 Capital Invests in OnePulse

Quill Appoints Gwyn Jones as Non-Executive Chairman

M&C Saatchi Mobile Earn-Out Completed

D5 Capital Raises £1.2m for MyShowcase

Spot.IM Launches Embedded Social Network for Publishers

D5 Capital advises Galliard on £13m sale

Novak Djokovic & Billie Jean King invest alongside D5 Capital and Bill Ackman in $3.5m PlaySight Series B funding

M&C Saatchi Mobile secondary sale

Smedvig Capital leads GBP 5m investment in Quill

Further participation in Spot.IM

Wix passes the $1 billion milestone

Wix IPO on NASDAQ

Soluto sold to Asurion for $100m

PlaySight accelerates growth with Loan Note

D5 Capital in content marketing deal

Walkme named ‘cool vendor’ by Gartner

Showbox completes Seed Round

D5 Capital Launches Angel Investor Club

Wix USA IPO

Rentify backed by Balderton

D5 Capital raises $1.5m for Sports Analytics Company

D5 Capital backs Rentify

Whitefox launches new publishing services group

Investis Sold to Gresham Private Equity

Making Millions from Creativity

Please walk me thru’ the web…

Videojug: Majority Stake Acquired by MLC50

M&C Saatchi gets Inside track

Four buys content PR experts

WPP builds out technology PR network

Financial Dynamics in Good Health

Making Money in Bear Markets

Cello Plays A Different Tune

Red Letter Day For Red Door

Huntsworth buys Avenue HKM